← Back to Search

Behavioral Intervention

Communication Bridge™ for Primary Progressive Aphasia (CB3 Pilot Trial)

N/A

Waitlist Available

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

Awards & highlights

CB3 Pilot Trial Summary

This trial will evaluate evidence-based treatments to improve communication and quality of life for adults with PPA and their care-partners. Participants will receive free speech therapy, access to a web application, and more.

Eligible Conditions

Dementia
Alzheimer's Disease
Primary Progressive Aphasia
Aphasia
Communication

CB3 Pilot Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: 5 assessment time points through study completion, an average of 1 year, including change over time

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 5 assessment time points through study completion, an average of 1 year, including change over time for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Communication Confidence PROM

CB3 Pilot Trial Design

1Treatment groups

Experimental Treatment

Group I: Experimental: Communication Bridge™Experimental Treatment1 Intervention

Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Communication Bridge™

2018

N/A

~110

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,005,106 Total Patients Enrolled

265 Trials studying Dementia

23,623,403 Patients Enrolled for Dementia

Northwestern UniversityLead Sponsor

1,585 Previous Clinical Trials

917,223 Total Patients Enrolled

7 Trials studying Dementia

100,442 Patients Enrolled for Dementia

Media Library

Communication Bridge™ (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05697380 — N/A

Dementia Research Study Groups: Experimental: Communication Bridge™

Dementia Clinical Trial 2023: Communication Bridge™ Highlights & Side Effects. Trial Name: NCT05697380 — N/A

Communication Bridge™ (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05697380 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project including participants over the age of 80?

"This medical research is accepting participants who are aged 18 and up, but under the century mark."

Answered by AI

Could I potentially qualify for this experiment?

"Prospective participants in this trial must have a diagnosis of Alzheimer's disease and range from 18 to 100 years old. This clinical study is currently seeking 30 individuals for enrollment."

Answered by AI

How many volunteers have signed up to participate in this experiment?

"Affirmative. Clinicaltrials.gov's records reflect that this medical trial is actively seeking enrolment, having initially gone public on February 1st 2023 and being updated as recently as March 23rd of the same year. 30 patients need to be recruited from a single location."

Answered by AI

Is the opportunity to participate in this trial still accessible for prospective candidates?

"Affirmative. According to information available on clinicaltrials.gov, this experiment has been seeking participants since the 1st of February 2023 and was last updated on March 23rd 2023. 30 individuals are being recruited from one location for participation in this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)

Emily Rogalski 2021. "CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05697380.